Communiqués

11/03/15 Salix Pharmaceuticals : Confirms Receipt of an Unsolicited Proposal from Endo International plc BU
02/03/15 Salix Pharmaceuticals : Reports 4Q2014 and FY2014 Results BU
28/02/15 Salix Pharmaceuticals : SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Salix Pharmaceuticals, Ltd. And Encourages Investors To Contact The Firm For Additional Information BU
27/02/15 Salix Pharmaceuticals : Stockholders Encouraged to Contact Securities Law Firm about Takeover PR
26/02/15 SALIX PHARMACEUTICALS : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout BU
25/02/15 Salix Pharmaceuticals : Provides Notice of Anticipated Make-Whole Fundamental Change to Holders of Its 1.5% Convertible Senior Notes Due 2019 BU
25/02/15 Salix Pharmaceuticals : Provides Notice of Anticipated Make-Whole Fundamental Change to Holders of Its 2.75% Convertible Senior Notes Due 2015 BU
24/02/15 Salix Pharmaceuticals : UPDATE - INVESTOR ALERT: Levi & Korsinsky, LLP Commences an Investigation of the Board of Directors of SALIX PHARMACEUTICALS, LTD. In Connection With the Fairness of the SALE OF THE COMPANY TO VALEANT PHARMACEUTICALS INTERNATIONAL, INC. -- SLXP PR
24/02/15 Salix Pharmaceuticals : Finkelstein Thompson LLP : Investigates Potentially Unfair Buyout of Salix Pharmaceuticals, Ltd. BU
24/02/15 Salix Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Salix Pharmaceuticals Ltd. PR
23/02/15 Salix Pharmaceuticals : SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Salix Pharmaceuticals, Ltd. And Encourages Investors To Contact The Firm For Additional Information BU
23/02/15 Salix Pharmaceuticals : UPDATE - INVESTOR ALERT: Levi & Korsinsky, LLP Commences an Investigation of the Board of Directors of Salix Pharmaceuticals, Ltd. in Connection with the Fairness of the Sale of the Company to Valeant Pharmaceuticals International, Inc. BU
23/02/15 Salix Pharmaceuticals : ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Pharmaceuticals to Valeant Pharmaceuticals International, Inc. BU
16/02/15 Salix Pharmaceuticals : Announces 4Q and FY2014 Financial Results Conference Call and Webcast BU
02/02/15 Salix Pharmaceuticals : Announces the Promotion of William P. Forbes, PharmD to President, Medical, R&D and Chief Development Officer BU
30/01/15 Salix Pharmaceuticals : Federman & Sherwood : Investigates Salix Pharmaceuticals, Ltd. for Possible Violations of Federal Securities Laws BU
28/01/15 Salix Pharmaceuticals : Provides Update on Audit Committee Review BU
10/01/15 Salix Pharmaceuticals : The Shuman Law Firm : Investigates Salix Pharmaceuticals Ltd. BU
05/01/15 Salix Pharmaceuticals : Carolyn Logan to Retire as Chief Executive Officer of Salix Pharmaceuticals BU
02/01/15 Salix Pharmaceuticals : SLXP Investor Alert: Levi & Korsinsky, LLP Reminds Investors of Class Action against Salix Pharmaceuticals, Ltd. and Its Board of Directors and a Lead Plaintiff Deadline of January 6, 2015 BU
02/01/15 Salix Pharmaceuticals : INVESTOR ALERT: Investors of Salix Pharmaceuticals, Ltd. with Losses of $100,000 or More Are Encouraged to Contact Law Offices of Howard G. Smith BU
30/12/14 Salix Pharmaceuticals : INVESTOR ALERT: Investors of Salix Pharmaceuticals, Ltd. With Losses of $100,000 or More Are Encouraged to Contact Glancy Binkow & Goldberg LLP BU
24/12/14 Salix Pharmaceuticals : DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Salix Pharmaceuticals, Ltd. Of Upcoming Deadline BU
17/12/14 Salix Pharmaceuticals : Lieff Cabraser Reminds Salix Pharmaceuticals, Inc. Investors of January 6, 2015 Lead Plaintiff Deadline in Class Litigation - SLXP BU
16/12/14 Salix Pharmaceuticals : SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Salix Pharmaceuticals, Ltd. To Contact Brower Piven Before The January 6, 2015 Lead Plaintiff Deadline In Class Action Lawsuit BU
Aucun résultat pour cette recherche